Hot Pursuit     12-Feb-24
Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
Zydus Lifesciences Ltd is quoting at Rs 861.45, up 7.01% on the day as on 12:49 IST on the NSE. The stock is up 82.72% in last one year as compared to a 21.78% gain in NIFTY and a 52.03% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 861.45, up 7.01% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.65% on the day, quoting at 21641.95. The Sensex is at 71152.48, down 0.62%. Zydus Lifesciences Ltd has added around 20.17% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 6.45% in last one month and is currently quoting at 18617.1, up 0.18% on the day. The volume in the stock stood at 51.87 lakh shares today, compared to the daily average of 12.72 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 860.4, up 6.65% on the day. Zydus Lifesciences Ltd is up 82.72% in last one year as compared to a 21.78% gain in NIFTY and a 52.03% gain in the Nifty Pharma index.

The PE of the stock is 32.71 based on TTM earnings ending September 23.

Previous News
  Zydus Lifesciences gains as board mulls share buyback
 ( Hot Pursuit - 06-Feb-24   09:33 )
  Zydus Life gets US FDA approval for antiretroviral medication Darunavir
 ( Hot Pursuit - 15-Dec-23   09:42 )
  Zydus Life gets US FDA nod for seizure treatment drug Lacosamide
 ( Hot Pursuit - 16-Dec-23   15:37 )
  Zydus Lifesciences consolidated net profit declines 25.36% in the March 2023 quarter
 ( Results - Announcements 18-May-23   14:49 )
  Volumes spurt at Zydus Lifesciences Ltd counter
 ( Hot Pursuit - 18-Dec-23   11:00 )
  Zydus Life gets USFDA nod for seizure drug
 ( Hot Pursuit - 04-Jul-23   13:06 )
  Zydus receives USFDA approves for Sucralfate Tablets
 ( Corporate News - 04-May-23   19:59 )
  Zydus' unit at Pharmex, Ahmedabad receives EIR from USFDA
 ( Corporate News - 03-Jul-23   12:19 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Life Ahmedabad unit gets 6 observations
 ( Hot Pursuit - 23-Dec-23   15:08 )
  Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
 ( Corporate News - 24-May-24   16:02 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top